Generic Name and Formulations:
Phenylephrine 1%, ketorolac 0.3%; intraocular soln after dilution.
Indications for OMIDRIA:
To maintain pupil size by preventing intraoperative miosis and reducing post-op ocular pain during cataract surgery or intraocular lens replacement, when added to an ocular irrigating solution.
Adults and Children:
Dilute 4mL of solution in 500mL of ocular irrigating solution. Use as needed for surgical procedure.
May elevate blood pressure. Aspirin or NSAID sensitivity. History of asthma. Pregnancy (avoid in 3rd trimester). Nursing mothers.
Alpha-1 agonist + NSAID.
Eye irritation, posterior capsule opacification, increased intraocular pressure, anterior chamber inflammation.
Single-patient-use vials (4mL)—4, 10
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|